InvestorsHub Logo
Followers 7
Posts 410
Boards Moderated 0
Alias Born 06/04/2014

Re: GentleGiant123 post# 1511

Tuesday, 03/07/2017 1:57:03 PM

Tuesday, March 07, 2017 1:57:03 PM

Post# of 21531
GentleGiant, thank you for your informative posts and the benefit of your obvious technical background in medical research.

Assuming that NTRP announces a positive outcome in their Ph2b study (and I am assuming they will based on animal studies, compassionate use cases, and the recent positive public statements by company officers) what, in your opinion, will be the most expeditious route for securing FDA approval for the use of Byrostating 1 in treating AD?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News